SCHEMBL8614772

SCHEMBL8614772

COc1c(OC)c(OC)c2c(C(=O)NC(N)=Nc3ccccc3)ccnc2c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 13/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SCNN1A P37088 1/20 0.43
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GMNN O75496 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
HPGD P15428 1/20 0.42
NFKB1 P19838 1/20 0.42
THPO P40225 1/20 0.42
STAT6 P42226 1/20 0.42
RECQL P46063 1/20 0.42
PMP22 Q01453 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8614046 0.87 SMO (0.49) SMOALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8616484 0.87 SMO (0.49) SMOALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8614354 0.84 SMO (0.43) SMOALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8613207 0.83 SMO (0.49) SMOALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8619835 0.83 SMO (0.49) SMOALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8617949 0.82 SMO (0.46) SMOALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8614883 0.82 SMO (0.46) SMOALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8617725 0.79 PDE4A (0.46) SMOALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8620636 0.79 NPC1 (0.49) SMOALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8618668 0.77 SMO (0.43) SMOALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed